Retinoids in cancer therapy and chemoprevention: promise meets resistance
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Retinoids (natural and synthetic derivatives of vitamin A) signal potent differentiation and growth-suppressive effects in diverse normal, premalignant, and malignant cells. A strong rationale exists for the use of retinoids in cancer treatment and chemoprevention based on preclinical, epidemiological, and early clinical findings. Despite the success of all-trans-retinoic acid (RA)-based differentiation therapy in acute promyelocytic leukemia (APL), the broad promise of retinoids in the clinic has not yet been realized. In addition to the expected limited activity of any single therapeutic agent, translation of retinoid activities from the laboratory to the clinic has met with intrinsic or acquired retinoid resistance. Evidence suggests that solid tumors develop intrinsic resistance to retinoids during carcinogenesis. In contrast, relapse of APL is often associated with acquired resistance to retinoid maturation induction. This review discusses what is known about retinoid resistance mechanisms in cancer therapy and chemoprevention. Strategies to overcome this resistance will be discussed, including combination therapy with other differentiation-inducing, cytotoxic or chromatin-remodeling agents, as well as the use of receptor-selective and nonclassical retinoids. Opportunities exist in the post-genomic era to bypass resistance to classical retinoids by identifying target genes and associated pathways that directly mediate the antineoplastic effects of retinoids. In this rega…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, developing resistance to ATRA treatment by tumors is common”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [349]
Citations
Cites
Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., & Golub, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2907 · Cited by 2,923
Self-citationHörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN
Wolbach, S. B., & Howe, P. R. (1925) · Journal of Experimental Medicine · doi:10.1084/jem.42.6.753 · Cited by 1,647
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
The Retinoids-Biology, Chemistry and Medicine
Wolf, G. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.5.796a · Cited by 998
Coactivator and corepressor complexes in nuclear receptor function
Xu, L., Glass, C. K., & Rosenfeld, M. G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80021-5 · Cited by 902
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V., Gamble, M., Näär, A. M., Erdjument-Bromage, H., Tempst, P., & Freedman, L. P. (1999) · Nature · doi:10.1038/19783 · Cited by 729
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614
Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.
Fondell, J. D., Ge, H., & Roeder, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8329 · Cited by 578
Transcriptional coactivator complexes.
Näär, A. M., Lemon, B. D., & Tjian, R. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.475 · Cited by 571
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
Coregulator codes of transcriptional regulation by nuclear receptors
Rosenfeld, M. G., & Glass, C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100041200 · Cited by 509 · cited 2×
“Comprehensive reviews of coactivators have been previously published (Naar et al., 2001; Rachez and Freedman, 2001; Rosenfeld and Glass, 2001).”
BackgroundThe retinoids; Biology, chemistry, and medicine
Kaster, P. (1994) · Biochimie · doi:10.1016/0300-9084(94)90131-7 · Cited by 467
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
A Transcriptional Switch Mediated by Cofactor Methylation
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., & Evans, R. M. (2001) · Science · doi:10.1126/science.1065961 · Cited by 416
Lotan, R., Xu, X.-C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., & Hong, W. K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322103 · Cited by 408
White, J. A., Beckett-Jones, B., Guo, Y.-D., Dilworth, F. J., Bonasoro, J., Jones, G., & Petkovich, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18538 · Cited by 402
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Acute leukemia with promyelocytic features in PML/RARα transgenic mice
He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., & Pandolfi, P. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5302 · Cited by 339
Retinoids and their receptors in cancer development and chemoprevention
Sun, S.-Y., & Lotan, R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00144-5 · Cited by 324
Lippman, S. M., Lee, J. J., Karp, D. D., Vokes, E. E., Benner, S. E., Goodman, G. E., Khuri, F. R., Marks, R., Winn, R. J., Fry, W., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.605 · Cited by 321
Collins, S. J., Robertson, K. A., & Mueller, L. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2154 · Cited by 318
He, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
Budhu, A. S., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2632-2641.2002 · Cited by 296
Mediator complexes and transcription
Rachez, C., & Freedman, L. P. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00209-x · Cited by 281
Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.
Houle, B., Rochette-Egly, C., & Bradley, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.985 · Cited by 280
A Novel Fusion Between MOZ and the Nuclear Receptor Coactivator TIF2 in Acute Myeloid Leukemia
Carapeti, M., Aguiar, R. C. T., Goldman, J. M., & Cross, N. C. P. (1998) · Blood · doi:10.1182/blood.v91.9.3127 · Cited by 272
Reactivating the expression of methylation silenced genes in human cancer
Karpf, A. R., & Jones, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205602 · Cited by 264
Selectivity of chromatin-remodelling cofactors for ligand-activated transcription
Lemon, B., Inouye, C., King, D. S., & Tjian, R. (2001) · Nature · doi:10.1038/414924a · Cited by 262
Methylation and Silencing of the Retinoic Acid Receptor- 2 Gene in Breast Cancer
Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.826 · Cited by 259
Lin, R. J., & Evans, R. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80322-6 · Cited by 232
Lampron, C., Rochette-Egly, C., Gorry, P., Dollé, P., Mark, M., Lufkin, T., LeMeur, M., & Chambon, P. (1995) · Development · doi:10.1242/dev.121.2.539 · Cited by 226
Maurer, B. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1897 · Cited by 215
Translocations of the RARα gene in acute promyelocytic leukemia
Zelent, A., Guidez, F., Melnick, A., Waxman, S., & Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204766 · Cited by 207
Xu, X.-C., Sozzi, G., Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K., & Lotan, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.624 · Cited by 201
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204593 · Cited by 180
Delva, L., Cornic, M., Balitrand, N., Guidez, F., Miclea, J., Delmer, A., Teillet, F., Fenaux, P., Castaigne, S., & Degos, L. (1993) · Blood · doi:10.1182/blood.v82.7.2175.2175 · Cited by 180
Transcription therapy for cancer
Pandolfi, P. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204299 · Cited by 179
Robertson, K., Emami, B., & Collins, S. (1992) · Blood · doi:10.1182/blood.v80.8.1885.1885 · Cited by 179
Retinoid X receptor and its partners in the nuclear receptor family
Rastinejad, F. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00165-2 · Cited by 175
Warrell, R. J. (1993) · Blood · doi:10.1182/blood.v82.7.1949.1949 · Cited by 175
McCaffery, P., & Dräger, U. C. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00002-2 · Cited by 162
Wu, Q. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1656 · Cited by 158
Retinoic acid resistance in acute promyelocytic leukemia
Gallagher, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402719 · Cited by 157
Shao, W., Benedetti, L., Lamph, W. W., Nervi, C., & Miller, W. H. (1997) · Blood · doi:10.1182/blood.v89.12.4282 · Cited by 147
Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer
Picard, E., Seguin, C., Monhoven, N., Rochette-Egly, C., Siat, J., Borrelly, J., Martinet, Y., Martinet, N., & Vignaud, J. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1059 · Cited by 147
Dimberg, A., Bahram, F., Karlberg, I., Larsson, L.-G., Nilsson, K., & Öberg, F. (2002) · Blood · doi:10.1182/blood.v99.6.2199 · Cited by 142
RETINOID THERAPY OF CHILDHOOD CANCER
Reynolds, C. P., & Lemons, R. S. (2001) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70256-2 · Cited by 137
Wallberg, A. E., Neely, K. E., Hassan, A. H., Gustafsson, J.-Å., Workman, J. L., & Wright, A. P. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2004-2013.2000 · Cited by 134
Nakayama, T., Watanabe, M., Yamanaka, M., HIROKAWA, Y. S., Suzuki, H., Itô, H., Yatani, R., & Shiraishi, T. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780316 · Cited by 132
Macdonald, F., Ford, C. H. J., & Casson, A. G. (1997) · Nature Medicine · doi:10.1038/nm1097-1163b · Cited by 131
van der Burg, B., van der Leede, B. M., Isbrücker, L., Salverda, S., de Laat, S. W., & van der Saag, P. T. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90267-n · Cited by 123
Piazza, F., Gurrieri, C., & Pandolfi, P. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204855 · Cited by 121
Zhou, D.-C., Kim, S. H., Ding, W., Schultz, C., Warrell, R. P., & Gallagher, R. E. (2002) · Blood · doi:10.1182/blood.v99.4.1356 · Cited by 118
Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052011299 · Cited by 117 · cited 1×
“Transfection of UBE1L results in PML-RARa degradation, and in NB4 cells triggers apoptosis but not differentiation (Kitareewan et al., 2002).”
BackgroundSelf-citationt, S. C., Sinnett, D., & Momparler, R. L. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199810000-00001 · Cited by 116
Transgenic expression of PML/RARalpha impairs myelopoiesis.
Early, E., Moore, M. A., Kakizuka, A., Nason-Burchenal, K., Martin, P., Evans, R. M., & Dmitrovsky, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7900 · Cited by 112
Self-citationThe Retinoids and Cancer Prevention Mechanisms
Dragnev, K. H., Rigas, J. R., & Dmitrovsky, E. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-361 · Cited by 112
Self-citationDNA Methyltransferase Inhibition Induces the Transcription of the Tumor Suppressor p21
Milutinovic, S., Knox, J. D., & Szyf, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6353 · Cited by 111
Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer
Иванова, Т. А., Petrenko, A. A., Gritsko, T. M., Vinokurova, S., Eshilev, E., Kobzeva, V., Kisseljov, F. L., & Kisseljova, N. P. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-4 · Cited by 105
Lung tumors in mice expressing an antisense RARβ2 transgene
Bérard, J., Laboune, F., Mukuna, M., Massé, S., Kothary, R., & Bradley, W. E. C. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801172 · Cited by 105
Kizaki, M., Ueno, H., Yamazoe, Y., Shimada, M., Takayama, N., Muto, A., Matsushita, H., Nakajima, H., Morikawa, M., Koeffler, H., et al. (1996) · Blood · doi:10.1182/blood.v87.2.725.bloodjournal872725 · Cited by 102
Genomic and proteomic analysis of the myeloid differentiation program
Lian, Z., Wang, L., Yamaga, S., Bonds, W., Beazer-Barclay, Y., Kluger, Y., Gerstein, M., Newburger, P. E., Berliner, N., & Weissman, S. M. (2001) · Blood · doi:10.1182/blood.v98.3.513 · Cited by 101
Dermime, S., Grignani, F., Clerici, M., Nervi, C., Sozzi, G., Talamo, G., Marchesi, E., Formelli, F., Parmiani, G., Pelicci, P. G., et al. (1993) · Blood · doi:10.1182/blood.v82.5.1573.1573 · Cited by 100
Freemantle, S. J., Kerley-Hamilton, J. S., Olsen, S. L., Gross, R., & Spinella, M. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205408 · Cited by 99
Self-citationLoss of Retinoic Acid Receptor-β Expression Is an Early Event during Esophageal Carcinogenesis
Qiu, H., Zhang, W., El‐Naggar, A. K., Lippman, S. M., Lin, P.-Z., Lotan, R., & Xu, X.-C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65467-3 · Cited by 98
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
Van heusden, J., Van Ginckel, R., Bruwiere, H., Moelans, P., Janssen, B., Floren, W., van der Leede, B. J., van Dun, J., Sanz, G., Venet, M., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600056 · Cited by 86
Nehmé, A., Varadarajan, P., Sellakumar, G., Gerhold, M., Niedner, H., Zhang, Q., Lin, X., & Christen, R. D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1818 · Cited by 85
Reynolds, C. P., Wang, Y., Melton, L. J., Einhorn, P. A., Slamon, D., & Maurer, B. J. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20001201)35:6<597::aid-mpo23>3.0.co;2-b · Cited by 85
Constitutive Degradation of PML/RAR Through the Proteasome Pathway Mediates Retinoic Acid Resistance
Fanelli, M., Minucci, S., Gelmetti, V., Nervi, C., Gambacorti-Passerini, C. B., & Pelicci, P. G. (1999) · Blood · doi:10.1182/blood.v93.5.1477 · Cited by 81
Moghal, N., & Neel, B. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3945 · Cited by 74
Dokmanovic, M., Chang, B.-D., Fang, J., & Roninson, I. B. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.35 · Cited by 70
Conley, B., O’Shaughnessy, J., Prindiville, S., Lawrence, J., Chow, C., Jones, E., Merino, M. J., Kaiser-Kupfer, M. I., Caruso, R. C., Podgor, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.275 · Cited by 70
C??t??, S., & Momparler, R. L. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199701000-00007 · Cited by 67
Inactivation of retinoic acid receptor β by promoter CpG hypermethylation in gastric cancer
Hayashi, K., Yokozaki, H., Oue, N., Suzuki, T., Yasui, W., Tahara, E., Goodison, S., & Lotan, R. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.068001013.x · Cited by 66
Petti, M. C., Fazi, F., Gentile, M., Diverio, D., De Fabritiis, P., De Propris, M. S., Fiorini, R., Spiriti, M. A. A., Padula, F., Pelicci, P. G., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0368 · Cited by 66
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
Coffey, D. C., Kutko, M. C., Glick, R. D., Swendeman, S. L., Butler, L. M., Rifkind, R. A., Marks, P. A., Richon, V. M., & LaQuaglia, M. P. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20001201)35:6<577::aid-mpo18>3.0.co;2-3 · Cited by 62
Curtin, J. C., Dragnev, K. H., Sekula, D., Christie, A. J., Dmitrovsky, E., & Spinella, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204370 · Cited by 59
Self-citationCytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy
Njar, V. (2002) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557023406223 · Cited by 57
Kitareewan, S., Spinella, M. J., Allopenna, J. J., Reczek, P. R., & Dmitrovsky, E. (1999) · Oncogene · doi:10.1038/sj.onc.1202981 · Cited by 54
Self-citationCheer, S. M., & Foster, R. H. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001050-00005 · Cited by 52
RARβ2-Mediated Growth Inhibition in HeLa Cells
Si, S. P., Lee, X., Tsou, H. C., Buchsbaum, R. J., Tibaduiza, E. C., & Peacocke, M. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0062 · Cited by 51
Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha
Li, Y., Said, F., & Gallagher, R. (1994) · Blood · doi:10.1182/blood.v83.11.3298.3298 · Cited by 51
Regulation of SMRT and N-CoR Corepressor Function
Privalsky, M. L. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_6 · Cited by 50
Demary, K. C., Wong, L., Liou, J. S., Faller, D. V., & Spanjaard, R. A. (2001) · Endocrinology · doi:10.1210/endo.142.6.8201 · Cited by 49
Targeting the PML/RARα translocation product triggers apoptosis in promyelocytic leukemia cells
Nason-Burchenal, K., Takle, G. Β., Pace, U., Flynn, S., Allopenna, J. J., Martin, P., George, S. T., Goldberg, A. R., & Dmitrovsky, E. (1998) · Oncogene · doi:10.1038/sj.onc.1202075 · Cited by 46
Self-citationCyclin Proteolysis as a Retinoid Cancer Prevention Mechanism
DRAGNEV, K. H., FREEMANTLE, S. J., SPINELLA, M. J., & DMITROVSKY, E. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb02724.x · Cited by 43
Self-citationBenedetti, L., Levin, A. A., Scicchitano, B. M., Grignani, F., Allenby, G., Diverio, D., Lo Coco, F., Avvisati, G., Ruthardt, M., Adamo, S., et al. (1997) · Blood · doi:10.1182/blood.v90.3.1175 · Cited by 41
Khuri, F. R., & Lippman, S. M. (2000) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(200003)18:2<100::aid-ssu3>3.0.co;2-9 · Cited by 39
Nason-Burchenal, K., Maerz, W., Allopenna, J. J., Martin, P., Dmitrovsky, E., Albanell, J., & Moore, M. A. S. (1997) · Differentiation · doi:10.1046/j.1432-0436.1997.6150321.x · Cited by 39
Self-citationNuclear Retinoid Receptors and Mechanisms of Action
Piedrafita, F. J., & Pfahl, M. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58483-1_5 · Cited by 37
The Retinoids: Cancer Therapy and Prevention Mechanisms
Nason-Burchenal, K., & Dmitrovsky, E. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58483-1_10 · Cited by 34
Self-citationLiposomal-all-trans-retinoic Acid in Treatment of Acute Promyelocytic Leukemia
Özpolat, B., & Lopez‐Berestein, G. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290021678 · Cited by 34
RARβ2 specificity in mediating RA inhibition of growth of lung cancer-derived cells
Toulouse, A. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00122-1 · Cited by 34
Spinella, M. J., Kitareewan, S., Mellado, B., Sekula, D., Khoo, K., & Dmitrovsky, E. (1998) · Oncogene · doi:10.1038/sj.onc.1201876 · Cited by 34
Self-citationTakeshita, A., Shinjo, K., Naito, K., Ohnishi, K., Sugimoto, Y., Yamakawa, Y., Tanimoto, M., Kitamura, K., Naoe, T., & Ohno, R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01823.x · Cited by 32
Pendino, F., Sahraoui, T., Lanotte, M., & Ségal-Bendirdjian, E. (2002) · Leukemia · doi:10.1038/sj.leu.2402470 · Cited by 31
Retinoic Acid Synthesis and Metabolism
Blaner, W. S., Piantedosi, R., Sykes, A., & Vogel, S. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58483-1_4 · Cited by 30
Fenretinide and cancer prevention
Torrisi, R., & DeCensi, A. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0077-x · Cited by 29
Matsushita, H., Kizaki, M., Kobayashi, H., Ueno, H., Muto, A., Takayama, N., Awaya, N., Kinjo, K., Hattori, Y., & Ikeda, Y. (1998) · Blood · doi:10.1182/blood.v91.7.2452 · Cited by 29
Molecular Mechanisms of Corepressor Function
Urnov, F. D., Wolffe, A. P., & Guschin, D. Y. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_1 · Cited by 25
Nowfar, S., Teplitzky, S., Mélançon, K., Kiefer, T. L., Cheng, Q., Dwivedi, P. D., Bischoff, E. D., Moroz, K., Anderson, M. B., Dai, J., et al. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014912919470 · Cited by 24
Calleja, E. M., & Warrell, R. P. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0105-x · Cited by 22
Management of acute promyelocytic leukemia
Tallman, M. S., & Nabhan, C. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0031-1 · Cited by 21
Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention
Zujewski, J. A. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10054 · Cited by 16
Robertson, K., Emami, B., & Collins, S. (1992) · Blood · doi:10.1182/blood.v80.8.1885.bloodjournal8081885 · Cited by 16
The Treatment of Cutaneous T-Cell Lymphoma with a Novel Retinoid
HEALD, P. W. (2000) · Clinical Lymphoma · doi:10.3816/clm.2000.s.009 · Cited by 13
Constitutive Degradation of PML/RAR Through the Proteasome Pathway Mediates Retinoic Acid Resistance
Fanelli, M., Minucci, S., Gelmetti, V., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1477.405a33_1477_1481 · Cited by 10
Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha
Li, Y., Said, F., & Gallagher, R. (1994) · Blood · doi:10.1182/blood.v83.11.3298.bloodjournal83113298 · Cited by 9
Guernsey, D. L., & Yen, A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420419 · Cited by 8
Mori, J.-I., Suzuki, S., Hara, M., Kaneko, A., Yamashita, K., Kumagai, M., Sakuma, T., Kakizawa, T., Yamazaki, M., Takeda, T., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00798.x · Cited by 8
Delva, L., Cornic, M., Balitrand, N., et al. (1993) · Blood · doi:10.1182/blood.v82.7.2175.bloodjournal8272175 · Cited by 8
The Retinoids and Cancer Chemoprevention
Kitareewan, S., Pitha, I., Ma, Y., Freemantle, S. J., & Dmitrovsky, E. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-767-3_18 · Cited by 7
Self-citationMatsushita, H., Kizaki, M., Kobayashi, H., et al. (1998) · Blood · doi:10.1182/blood.v91.7.2452.2452_2452_2458 · Cited by 4
Benedetti, L., Levin, A. A., Scicchitano, B. M., et al. (1997) · Blood · doi:10.1182/blood.v90.3.1175.1175_1175_1185 · Cited by 4
Brigati, C., Nobile, L. M., Fugazza, G., Zohouri, M., Gallagher, R. E., & Cannizzaro, L. A. (1999) · Leukemia Research · doi:10.1016/s0145-2126(98)00145-3 · Cited by 3
Slack, J. M. W. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1420-5_2 · Cited by 2
Research works printed but not linked: 1
- He LZ, Tolentino T, Grayson P, Zhong S, Warrell Jr RP, Rifkind RA, Marks PA, Richon VM and Pandolfi PP . (2001). J. Clin. Invest., 108, 1321–1330. · doi:10.1172/jci200111537 · Paper page
Cited by
Stem cell origin of cancer and differentiation therapy
Sell, S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.04.007 · Cited by 638
Retinoids, Retinoic Acid Receptors, and Cancer
Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling
Epping, M. T., Wang, L., Edel, M. J., Carlée, L., Hernandez, M., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.07.003 · Cited by 432
“Loss of RARβ expression is involved in the progression of a diverse range of solid tumors, including breast and lung carcinomas (Altucci and Gronemeyer, 2001; Freemantle et al., 2003).”
Metadata
- Authors
- Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E.
- Affiliations
- Dartmouth College (US)
- Corresponding author
- Freemantle, Sarah J
- Venue
- Oncogene
- Published
- 2003-10-20
- Volume
- 22
- Issue
- 47
- Pages
- 7305-7315
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2040347441
- Cited by
- 312
- References
- 121
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7k01ca075154-02)
- National Cancer Institute (R0-1 CA87546, R01-CA62275, R01CA062275, K01 CA 75154-01, R01CA087546)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- retinoids, vitamin A derivatives, retinoid resistance, chemoprevention, cancer therapy, differentiation therapy, all-trans retinoic acid, acute promyelocytic leukemia, relapse, combination therapy, chromatin remodeling, antineoplastic mechanism, carcinogenesis
- MeSH terms
- Humans, Neoplasms, Retinoids, Leukemia, Promyelocytic, Acute, Receptors, Retinoic Acid, Drug Resistance, Neoplasm, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.